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In order to limit the adverse effects of excessive inflammation, anti-inflammatory
responses are stimulated at an early stage of an infection, but during sepsis these
can lead to deactivation of immune cells including monocytes. In addition, there is
emerging evidence that the up-regulation of mitochondrial quality control mechanisms,
including mitochondrial biogenesis and mitophagy, is important during the recovery
from sepsis and inflammation. We aimed to describe the relationship between the
compensatory immune and mitochondrial responses that are triggered following
exposure to an inflammatory stimulus in human monocytic cells. Incubation with
lipopolysaccharide resulted in a change in the immune phenotype of THP-1 cells
consistent with the induction of endotoxin tolerance, similar to that seen in deactivated
septic monocytes. After exposure to LPS there was also early evidence of oxidative
stress, which resolved in association with the induction of antioxidant defenses and the
stimulation of mitochondrial degradation through mitophagy. This was compensated by
a parallel up-regulation of mitochondrial biogenesis that resulted in an overall increase
in mitochondrial respiratory activity. These observations improve our understanding of
the normal homeostatic responses that limit the adverse cellular effects of unregulated
inflammation, and which may become ineffective when an infection causes sepsis.
Keywords: inflammation, endotoxin tolerance, mitochondria, mtDNA, mitophagy, mitochondrial biogenesis,
antioxidants
INTRODUCTION
During sepsis an infection triggers a systemic inflammatory response, leading to organ dysfunction,
shock and a significant risk of mortality (1). The clinical outcome of sepsis appears to be determined
by the initial host inflammatory response to the infection and the subsequent compensatory
mechanisms leading to the resolution of this inflammation (2). The dysregulation of any of
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these processes may result in complications. In particular,
an excessive or prolonged immune deactivation phase later
in the sepsis illness leads to a vulnerability to nosocomial
infections and increased mortality (3). Deactivation of blood
monocytes, key innate immune cells, appears to be particularly
important during this sepsis-induced immune deactivation
but the mechanisms underlying this process are not well
understood (4–6).
There is increasing evidence that impaired cellular respiration
due to mitochondrial dysfunction during sepsis is associated with
adverse clinical outcomes and may lead to impaired monocyte
functions (7–9). Mitochondria are organelles with several
critical cellular functions, particularly the generation of cellular
energy at five enzyme complexes on the inner mitochondrial
membrane during oxidative phosphorylation (OXPHOS) (10).
The majority of mitochondrial constituents are encoded on
the nuclear genome but mitochondria also contain circular
mitochondrial DNA (mtDNA) with genes encoding 13 essential
OXPHOS complex subunits (11). During sepsis mitochondria
may become damaged or dysfunctional, leading to mtDNA
depletion, impaired cellular respiration, and cell death (12, 13).
The persistent presence of dysfunctional mitochondria can also
lead to oxidative stress, as mitochondria are the main source
of reactive oxygen species through the leakage of electrons
during OXPHOS, and act as a potent stimulus for ongoing
inflammation (14, 15).
The adverse effects of inflammation on mitochondria
can be abrogated by several mechanisms. These include the
induction of anti-inflammatory responses and antioxidant
defenses, maintenance of mitochondrial integrity through the
selective removal of dysfunctional mitochondria (mitophagy),
and the generation of new organelles to replace them
(mitochondrial biogenesis) (16, 17). However, the integration
of these compensatory responses, and the interaction between
mitochondria and immunity in monocytic cells following an
inflammatory insult, are not well understood. In order to study
these processes we assessed mitochondrial functions, biogenesis,
and mitophagy in a time course model of endotoxin tolerance,
a process whereby repeated exposure to lipopolysaccharide
(LPS) from Gram negative bacteria leads to a change in
immune phenotype similar to that seen in deactivated blood
monocytes (18).
Here we show that there is a reversible induction of
antioxidant defenses, mitophagy, and mitochondrial biogenesis
in THP-1 cells rendered endotoxin tolerant following exposure
to LPS, leading to a maintenance of cellular viability and
respiration. These findings suggest that these processes are
vital to cellular recovery following an inflammatory insult
and that dysregulation of these compensatory mechanisms
may contribute to adverse outcomes when an infection causes
sepsis.
MATERIAL AND METHODS
THP-1 Cell Culture and Reagents
All reagents were obtained from ThermoFisher Scientific
(Waltham, MA, USA) unless otherwise stated. THP-1 cells
(ATCC R©TIB-202TM) were kindly provided by Dr John Taylor’s
laboratory, Newcastle University. The cells were maintained
at a concentration of < 1 × 106 cells/ml in RPMI 1640
medium supplemented with 10% fetal calf serum (FCS) and
contaminationwithMycoplasmawas periodically excluded. In all
experiments 1× 106 THP-1 cells were incubated in 25 cm3 tissue
flasks containing 5ml growth medium to which LPS (100 ng/ml)
from Escherichia coli O26/B6 (Sigma-Aldrich, St Louis, MO,
USA) was added either 72 (t = 0 h), 48 (t = 24 h), 24 (t = 48 h),
6 (t = 66 h), or 2 (t = 70 h) h prior to the end of a 72 h pre-
incubation period. After this pre-incubation the THP-1 cells
were then pelleted, washed with PBS and re-suspended in fresh
medium before comparing immune andmitochondrial functions
to those in control cells pre-incubated for the previous 72 h in
growth medium without LPS. The dose of LPS used in this model
was selected on the basis of dose-finding experiments assessing
the optimal induction of endotoxin tolerance (Figure 1A).
E. coli O26/B6 LPS was chosen as we and others have shown
inhalation to produce reproducible inflammation in human
volunteers (19, 20).
Monocyte Isolation and Culture
Whole blood was obtained from 5 healthy volunteers
(ethical approval was obtained from the relevant Research
Ethics Committee and all volunteers provided informed,
written consent). Human peripheral blood mononuclear
cells (PBMCs) were extracted from the whole blood using
dextran (Pharmacosmos, Holbaek, Denmark) sedimentation
and Percoll (GE Healthcare Biosciences, Little Charlfort,
UK) density-gradient centrifugation (21). Using the MACS
Monocyte Isolation Kit II, MS columns and the Mini-
MACS Separator (all Miltenyi Biotec, Auburn, CA, USA)
monocytes were isolated from the PBMC fraction by negative
selection. The purity of isolated monocytes was confirmed
at >95% using morphological assessment following cytospin
with Giemsa staining. The monocytes were re-suspended
in IMDM medium supplemented with 10% autologous
human serum and cultured with or without 10 ng/ml
LPS for 24 h before measuring immune and mitochondrial
functions.
Detection of Cytokine Production
2.5 × 105 THP-1 cells or 1 × 105 monocytes in 500 µl growth
medium per well were seeded onto a 24 well plate (Grenier
Bio-one, Stonehouse, UK) and incubated for 4 h at 37◦C ±
LPS (100 ng/ml for THP-1 cells and 10 ng/ml for monocytes).
Subsequently, the release of TNFα and IL-8 in supernatant
samples was measured by enzyme-linked immunosorbent assay
(ELISA) using Novex R© Human Antibody Pair kits and following
the manufacturer’s protocol.
THP-1 Cell Viability
Cell viability was assessed by measuring the proportion of THP-
1 cells able to exclude propidium iodide (0.5µg/ml) using the
FACSCanto II flow cytometer (Becton Dickinson Biosciences,
Franklin Lakes, NJ, USA).
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FIGURE 1 | Pre-incubation of THP-1 cells with LPS results in a change in immune phenotype consistent with endotoxin tolerance. THP-1 cells were pre-incubated
with LPS (100 ng/ml) for 0–72 h and the ability to respond to a second inflammatory stimulus was then determined. (A) THP-1 cells were pre-incubated with 1, 10, or
100 ng/ml LPS for 24 h before measuring release of TNFα during a further 4-h exposure to a second stimulus of 10 or 100 ng/ml LPS by ELISA. (B)The release of
pro-inflammatory TNFα and IL-8 in response to a second exposure to LPS (100 ng/ml) was measured by ELISA (n = 6). (C) Phagocytosis of fluorescein-labeled
(Continued)
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FIGURE 1 | Escherichia coli (E.coli) in 1 h was measured by flow cytometry (n = 4). (D) Cell viability was determined by measuring the proportion of cells excluding
propidium iodide following incubation with LPS (100 ng/ml) for 0–72 h (n = 4). (E) THP-1 cells were incubated with LPS (100 ng/ml) for 0–72 h before measuring
macrophage differentiation in comparison to a positive control of cells treated with 10 nM PMA for 72 h. Representative images of THP-1 cell morphology on inversion
light microscope at 40x magnifications. (F) THP-1 cell adherence to a 6 well plate was determined by cell counts before and after removal of adherent cells using a cell
scraper (n = 3). (G) Flow cytometry was used to determine the relative signal intensity for the expression of the markers of macrophage differentiation CD14, CD36,
and CD206 compared to the mean in the medium control (n = 3) (H) Representative histograms indicating the level of cell surface CD14 expression measured by flow
cytometry. (I) Extracellular acidification rate with and without olygomycin following exposure to LPS (100 ng/ml) for 0–72 h as determined using the Seahorse XF96e
extracellular flux analyser (n = 5). All data are presented as mean ± standard deviation with the values in panel a expressed as relative cytokine release compared to
the mean in the medium control; *p < 0.05, **p < 0.01, ***p < 0.001.
Assessment of Differentiation of THP-1
Cells to Macrophage-Like Cells
A qualitative assessment of THP-1 cell morphology was carried
out by imaging a minimum of 100 cells in three separate wells
on a 6 well plate using a DMI3000 B inversion microscope
(Leica, Heidelberg, Germany). The adherence of THP-1 cells
to a 6 well plate after 72 h incubation was assessed by cell
counts before and after detaching any adherent cells using
a cell scraper. Furthermore, the expression of macrophage
differentiation markers CD14 (CD14-PECy7, 561385, Becton
Dickinson Biosciences), CD36 (CD36-PE, 336206, BioLegend,
San Diego, CA, USA), and CD206 (CD206-PE, 321106,
BioLegend) on the surface of THP-1 cells was measured
using the BD FACSCanto-II flow cytometer (Becton Dickinson
Biosciences). As a positive control THP-1 cells were differentiated
intomacrophage-like cells by incubation with 10 nMphorbol-12-
myristate 13-acetate (PMA) for 72 h (22).
MtDNA Sequencing and Bioinformatic
Analysis
This process was carried out as previously described by our group
(23). Firstly, mtDNA was enriched using long-range polymerase
chain reaction. In order to prevent contamination with nuclear-
mitochondrial sequences, amplicons were polymerised using
PrimeSTAR GXL DNA polymerase (error rate = 0.00108%,
Takara Bio, Saint-Germain-en-Laye, France) in two overlapping
fragments, using primer set-1: CCC TCT CTC CTA CTC
CTG-F (m.6222–6239) and CAG GTG GTC AAG TAT TTA
TGG–R (m.16133–16153), and set-2: CAT CTT GCC CTT
CAT TAT TGC–F (m.15295–15315) and GGC AGG ATA GTT
CAG ACG-R (7773–7791). Primer efficiency and specificity
was assessed as successful after no amplification of DNA from
ρ0 cell lines lacking mtDNA. Amplified products and DNA
positive/negative controls were assessed by gel electrophoresis,
and quantified using a Qubit 2.0 fluorimeter. Each amplicon
was individually purified using Agencourt AMPure XP beads
(Beckman-Coulter, USA), pooled in equimolar concentrations
and re-quantified. For the mtDNA sequencing pooled amplicons
were “tagmented,” amplified, cleaned, normalized, and pooled
into 48 sample multiplexes using the Illumina Nextera XT DNA
sample preparation kit (Illumina, CA, USA). The multiplex
pools were sequenced using MiSeq Reagent Kit v3.0 (Illumina,
CA, USA) in paired-end, 250 bp reads. Post run data, limited
to reads with QV ≥ 30, were exported for analysis. Post-
run FASTQ files were analyzed using an in-house developed
bioinformatic pipeline. Reads were aligned to the revised
Cambridge reference sequence (NC_012920) using BWA v0.7.10,
invoking–mem (24). Aligned reads were sorted and indexed
using Samtools v0.1.18 (25), duplicate reads were removed using
Picard v1.85 (http://broadinstitute.github.io/picard/). Variant
calling (including somatic calling) was performed in tandem
using VarScan v2.3.8 (26, 27) (minimum depth = 1,500,
supporting reads = 10, base-quality (BQ) ≥ 30, mapping quality
(MQ) ≥ 20 and variant threshold = 1.0%), and LoFreq v0.6.1
(28). Concordance calling between VarScan and LoFreq was
>99.5%. Concordant variants were annotated using ANNOVAR
v529 (29) In-house Perl scripts were used to extract base/read
quality data and coverage data.
Assessment of Mitochondrial Mass and
Respiratory Chain Enzyme Activity
The uptake of 2.5µM nonyl acridine orange (NAO, a dye that
localizes to cardiolipin on the mitochondrial inner membrane)
by THP-1 cells over 30min was determined by measuring
fluorescence (excitation wavelength 488 nm, bandpass filter
530/30 nm) using the FACSCanto-II flow cytometer (30). As a
positive control mitochondrial mass was increased in THP-1 cells
by pre-incubation for 72 h in DMEM supplemented with 5mM
galactose and lacking glucose (31).
Citrate synthase is a nuclear DNA-encoded enzyme that
catalyzes the initial reaction in the citric acid cycle in the
mitochondrial matrix and provides a quantitative marker
of cellular mitochondrial content (32). A spectrophotometric
assessment of the activity of citrate synthase on THP-1 cell
homogenate was carried out as previously described using the
MultiSkan Ascent plate reader (33). Complex IV activity was
determined by the rate of oxidation of reduced cytochrome C
using the Complex IV Human Specific Microplate Assay Kit
(Abcam Danvers, MA, USA).
Phagocytosis of Fluorescein-Labeled
Escherichia coli
Serum-opsonised fluorescein-labeled Escherichia coli K-12 strain
were incubated with THP-1 cells at a multiplicity of infection of
10:1 for 1 h at 37◦C. After washing and quenching extracellular
fluorescence through the addition of 0.1% trypan blue (Sigma-
Aldrich), the proportion of cells internalizing bacteria was then
measured using the FACSCanto II flow cytometer (Becton
Dickinson Biosciences, Franklin Lakes, NJ, USA).
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Mitochondrial Bioenergetics Assessment
Mitochondrial membrane potential was measured following
incubation with 5µM JC-1 (T3168) for 30min the red
(excitation wavelength 561 nm, bandpass filter 186/15 nm) and
green (488 nm, 530/30 nm) fluorescence using the LSRFortessa
X20 flow cytometer (Becton Dickinson Biosciences). As a
positive control cells were pre-treated for 10min with 100 nM
valinomycin, a potassium-selective ionophore that dissipates the
mitochondrial membrane potential (34). The production of ROS
was determined by measuring the oxidation of 1µM DCF-DA
(D399). After 30min the fluorescence (absorption wavelength
488 nm, band pass filter 530/30 nm) was measured on the BD
FACSCanto-II flow cytometer (35). As a positive control cells
were treated with 100µM hydrogen peroxide.
Mitochondrial respiration and Extracellular acidification rate
(ECAR) was determined using the Seahorse XF96e Extracellular
Flux analyser (both Seahorse Biosciences, Chickopee, MA, USA)
as previously described (36). 0.8 × 105 THP-1 cells were seeded
in 175 µl of an assay medium per well, consisting of MEM
supplemented with 11.1mM D-Glucose and 2mM L-Glutamine
and adjusted to pH 7.0. Oxygen consumption rate (OCR) was
measured at baseline and following the sequential addition of
1µM oligomycin (a complex V inhibitor), 0.5µM then 1µM
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (fCCP,
an electron transport chain uncoupler) and finally 1µMrotenone
(a complex III inhibitor) plus 1µM antimycin A (a complex I
inhibitor). During each of the four stages of the assessment the
OCR was measured in 16 wells per condition at 3 different time
points. All OCR data were normalized to the total protein per
well, which was determined using the Bradford assay.
Nucleic Acids Extraction and
Quantification by Real Time PCR
For the determination of mtDNA copy number total DNA was
extracted from cell pellets using the DNeasy blood and tissue kit
(Qiagen, Valencia, CA, USA). The relative mtDNA copy number
was determined by comparing the level of the mtDNA-encoded
MT-ND1 gene (primers: F - ACGCCATAAAACTCTTCACC
AAAG, R - GGGTTCATAGTAGAAGAGCGATGG) to that of
the nuclear reference gene B2M (primers: F - CACTGAAAAAG
ATGAGTATGCC, R - AACATTCCCTGACAATCCC) by real-
time quantitative polymerase chain reaction (qPCR) using the
SYBR R© Green technique and the MyiQTM PCR machine (both
BioRad, Hercules, CA, USA) (37).
In the quantification of mRNA levels, RNA was extracted
from pellets of 4 × 106 THP-1 cells using the RNeasy
mini kit (Qiagen) and single-stranded complementary DNA
(cDNA) was synthesized using the High Capacity cDNA Reverse
Transcription Kit. Following this the relative transcription
of specific genes was determined by RTqPCR using the
Taqman R© Gene Expression Assay (β-ACTIN-Hs01060665_g1,
GAPDH–Hs02758991_g1, HMOX1–Hs01110250_m1, SOD2–
Hs00167309_m1) and the 7500 Fast Real Time PCR System. The
relative amount of cDNA for each specific target was determined
by comparison with the control housekeeping genes ACTB and
GAPDH using the1Ct method.
Western Blot
THP-1 cells were lysed using a lysis buffer containing 1% Triton
X and the protease inhibitor phenylmethanesulfonyl fluoride
(1mM) (both Sigma-Aldrich) and the protein concentration
in the lysates determined by Bradford assay. Equal amounts
of protein were separated on the basis of size by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE), transferred onto polyvinylidene fluoride membranes
and blotted with different antibodies, assessing the signal
intensity after addition of an enhanced chemiluminescent
substrate using the MultiSpectral Imaging System (UVP,
Upland, CA, USA). The following antibodies were used;
anti-mouse Ig-HRP (0260) and anti-rabbit-HRP (0448) from
Dako (Cambridge, UK), β-actin (mouse, ab8226) and SOD2
(rabbit, ab13533) from Abcam (Danvers, MA, USA), LC3-
I/II (rabbit, CS54995) from Cell Signalling (Beverley, MA,
USA), Mitoprofile R© Total OXPHOS antibody cocktail (mouse,
MS604) from MitoSciences (Eugene, OR, USA) and TFAM
(mouse, NBP1-71648) from Novus Biological (Cambridge,
UK).
Measurement of Autophagy by Detection
of LC3-II by Western Blot–
Following a 2 h incubation in the presence or absence
of 10µM chloroquine (an inhibitor of autophagosome
degradation) protein was extracted from THP-
1 cells and the amount of LC3-II relative to the
housekeeping protein β-actin was determined by Western
blot.
Confocal Microscopy to Assess Mitophagy
Serum-starved THP-1 cells incubated in RPMI 1640 medium
without FCS for 2 h were used as a positive control for the
induction of mitophagy and treatment with 5 nM bafilomycin
A1 for 2 h was used to prevent autophagosome turnover.
The THP-1 cells were adhered to slides by cytospin, fixed
using 4% paraformaldehyde, permeabilised using 0.1% Triton
X, and blocked to prevent non-specific antibody binding using
2% bovine serum albumin. The slides were then incubated
with the primary antibodies (OXPHOS complex II–mouse,
459200, ThermoFisher Scientific; LC3-II–rabbit, CS54995, Cell
signaling) for 16 h at 4◦C, washed and incubated with
fluorochrome-conjugated secondary antibodies (anti-mouse
IgG-Oregon Green–O6380, anti-rabbit IgG-Alexa Fluor 568–
A11011) and the nuclear dye DAPI (D3571) for a further
2 h at room temperature. Co-localisation of LC3-II and
mitochondrial complex II was determined using the SB2 UV
confocal microscope and the X63 HCX PL APO lens (both
Leica, Heidelberg, Germany). Each experimental condition was
assessed in triplicate with images taken for a minimum of 100
cells over 3 separate fields of view for each slide. The images
were analyzed using Volocity software (PerkinElmer, Waltham,
MA, USA). Co-localisation of mitochondrial complex II and
LC3-II was assessed using the Mander’s M1 co-localisation co-
efficient (38).
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STATISTICAL ANALYSIS
All experiments were carried out on a minimum of three
biological replicates. The Shapiro-Wilk test was used to
determine the normality of the data. Normally distributed data
are presented as mean ± standard deviation, and were analyzed
using one-way analysis of variance (ANOVA) with Dunnett’s
post-hoc analysis or independent t-tests. Non-normal data are
presented as median and interquartile range and were analyzed
using the Kruskal-Wallis analysis of variance with Dunn’s post-
hoc analysis. A p-value of <0.05 was defined as the threshold for
statistical significance.
RESULTS
Pre-incubation With LPS Produces an
Endotoxin Tolerance Phenotype in THP-1
Cells
After an initial exposure to LPS (100 ng/ml) for 0–72 h the
ability of THP-1 cells to respond to a second inflammatory
stimulus was assessed. THP-1 cells pre-incubated with LPS for
2–48 h had a significantly reduced ability to release the pro-
inflammatory cytokines tumor necrosis factor alpha (TNFα) and
interleukin (IL)-8 in response to a second stimulation with LPS
(100 ng/ml) (Figure 1B). Conversely, following pre-incubation
with LPS the ability of THP-1 cells to phagocytose Escherichia coli
was significantly enhanced (Figure 1C). There was no evidence
that exposure to LPS adversely affected THP-1 cell viability
(Figure 1D). Study of the morphology (Figure 1E), adherence
capacity (Figure 1F) and cell surface markers (Figures 1G,H)
confirmed the absence of differentiation into macrophage-like
cells as compared with the positive control treated with PMA
for 72 h. Macrophage polarization correlates with changes in
metabolism (39). Similarly to the surface markers, measurement
of the Extracellular acidification rate of themedia, which is widely
used as glycolysis surrogate (40) did not show any changes after
LPS treatment (Figure 1I). These findings are consistent with a
change in immune phenotype of THP-1 cells following treatment
with LPS that is characteristic of the induction of endotoxin
tolerance (41).
Resolution of Early Oxidative Stress
Following Exposure of THP-1 Cells to LPS
Next, we studied the effects of LPS treatment on mitochondrial
dysfunction markers. We did not find any difference in the
mitochondrial membrane potential on LPS-treated THP-1 cells
(Figure 2A), confirming an absence of mitochondrial membrane
depolarization, a process that reflects the leakage of proton across
the innermitochondrial membrane due to a loss ofmitochondrial
integrity (20). However, there was an early increase in reactive
oxygen species production asmeasurement of hydrogen peroxide
(Figure 2B), accompanied with higher mRNA levels of heme
oxygenase-1, a gene that is up-regulated during oxidative
stress (Figure 2C) (42). The resolution of this LPS-induced
oxidative stress occurred in association with the stimulation
of antioxidant defenses, as evidenced by increased levels of
the mitochondrial antioxidant superoxide dismutase-2 (SOD2)
(Figure 2D). Despite being particularly vulnerable to oxidative
damage, we did not find any evidence of mtDNA deletions or
mutations in LPS-exposed THP-1 cells (Supplementary Table 1).
Thus, treatment of THP-1 cells with LPS leads to early oxidative
stress, a process that is reversed by the induction ofmitochondrial
antioxidant defenses.
An Early Induction of Mitophagy Following
Exposure of THP-1 Cells to LPS
Increased reactive oxygen species production is a feature of
mitochondrial dysfunction, which has been found to activate
mitophagy and target mitochondria for degradation (43).
Consistent with this, treatment with LPS was found to stimulate
both autophagy and mitophagy contemporaneously with the
generation of oxidative stress, during the first hours of exposure.
There was an early LPS-induced activation of autophagy, as
indicated by significantly increased accumulation of the LC3-
II protein, a constituent of the autophagosome, in THP-1 cells
after treatment with LPS for 2–6 h (Figure 3A). The induction
of mitophagy in LPS-treated THP-1 cells was then confirmed
through the measurement of co-localization of mitochondria to
autophagosomes using confocal microscopy (Figures 3B,C).
Induction of Mitochondrial Biogenesis and
Increased Mitochondrial Respiration in
LPS-Exposed THP-1 Cells
We next studied whether the induction of mitophagy after
treatment with LPS was associated with changes in the overall
mitochondrial mass. We did not observe changes in the level of
the internal membrane marker cardiolipin (Figure 4A) or the
matrix marker citrate synthase activity (Figure 4B), suggesting
that there must be a parallel replacement of any degraded
mitochondria. This was confirmed by assessments indicating that
there was an early and sustained activation of mitochondrial
biogenesis in THP-1 cells after LPS treatment. We observed a
significant increase in THP-1 cell mtDNA copy number in THP-
1 cells treated with LPS for 2–48 h (Figure 4C), that significantly
correlated with the level of mitochondrial transcription factor
A (TFAM), a key regulator of mitochondrial biogenesis that
is bound to mtDNA (Figures 4D,E). Furthermore, LPS-treated
THP-1 cells had a significant increase in protein levels for
constituents of the inner mitochondrial membrane OXPHOS
complexes I and IV, the two complexes containing the greatest
number of mtDNA-encoded proteins (Figure 4F) (44). These
results suggest that there is a coordinated up-regulation
of mitochondrial biogenesis and mitophagy, leading to the
maintenance of mitochondrial mass in THP-1 cells following an
inflammatory insult in the form of LPS treatment.
The overall functional consequences of the increases in
mitochondrial biogenesis and mitophagy were assessed by
measurement of mitochondrial oxygen consumption. It was
shown that exposure to LPS resulted in increased basal
mitochondrial respiration and mitochondrial ATP production
with no effect on non-mitochondrial oxygen consumption
(Figures 4G,H), findings consistent with the increased levels of
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FIGURE 2 | Exposure to LPS leads to early oxidative stress but no increase in mitochondrial membrane potential. Mitochondrial membrane potential (1ψm) and
oxidative stress were assessed following incubation of THP-1 cells with LPS (100 ng/ml) for 0–72 h. (A) The proportion of THP-1 cells with 1ψm was determined by
measuring the JC1 fluorescence by flow cytometry (positive control−100 nM valinomycin) (n = 3). (B) Reactive oxygen species production was measured by oxidation
of DCF-DA using flow cytometry (positive control−100µM hydrogen peroxide, H2O2) (n = 3). (C) The mRNA transcription of HMOX1 relative to ACTB and GADPH
was determined by RTqPCR (n = 3). (D) The mRNA transcription (relative to ACTB and GADPH) and protein expression (relative to β-actin) of SOD2 was measured
using RTqPCR and Western blot (n = 3). Data are presented as mean ± standard deviation (mRNA and protein data are relative to the mean of the medium control);
*p < 0.05, **p < 0.01, ***p < 0.001.
OXPHOS complexes I and IV (Figure 4F) and the increased
activity of isolated complex IV (Figure 4I). Thus, in association
with a shift to an endotoxin tolerance phenotype, THP-1 cells
exposed to LPS have early evidence of oxidative stress which
resolves in association with the induction of mitophagy and
mitochondrial biogenesis, resulting in maintained cell viability
and increased mitochondrial respiration.
Induction of Endotoxin Tolerance and
Mitochondrial Biogenesis in Human
Monocytes Treated With LPS
To confirm the relevance of the findings in THP-1 cells, human
monocytes were pre-incubated with medium or 10 ng/ml LPS
for 24 h before measuring cytokine release and mtDNA copy
number. The induction of endotoxin tolerance was indicated by
the finding that monocytes pre-incubated with LPS for 24 h had
a significantly reduced ability to release TNFα release in response
to a second exposure to LPS (Figure 5A). There was also a
significant increase in mtDNA copy number in those monocytes
treated with LPS, suggesting a similar induction of mitochondrial
biogenesis to that seen in THP-1 cells (Figure 5B).
DISCUSSION
The regulation of the compensatory pro-survival cellular
mechanisms that are triggered following an inflammatory
insult and the mechanisms by which they become deranged
during sepsis are not well understood. We have used an
endotoxin tolerance model to induce a temporary state of
immune deactivation in human monocytic cells resembling
that seen in septic monocytes (18). This shift to an anti-
inflammatory phenotype after exposure to LPS was found
to occur in parallel with the activation of responses aimed
at maintaining mitochondrial homeostasis; namely antioxidant
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FIGURE 3 | Induction of mitophagy in THP-1 cells following exposure to LPS. THP-1 cells were incubated with LPS (100 ng/ml) before measuring the levels of
autophagy and mitophagy. (A) Autophagic flux was assessed by measuring the accumulation of LC3-II relative to β-actin using Western blot (n = 3). (B) Confocal
microscopy provided a measure of mitophagy by measuring the co-localisation of mitochondrial complex II with the autophagosome marker LC3-II using the Mander’s
M1 co-localisation co-efficient (n = 4). (C) Representative confocal microscopy images with staining for the nucleus (blue), mitochondrial complex II (green), and LC3-II
(red) after incubation of THP-1 cells with LPS (100 ng/ml) for 0–6 h. In all experiments serum starvation was used a positive control and accumulation of
autophagosomes was facilitated by treatment with 10µM chloroquine (CQ) or 5 nM bafilomycin A1 for the final 2 h. Data are presented as mean ± standard deviation;
*p < 0.05, **p < 0.01.
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FIGURE 4 | Induction of mitochondrial biogenesis following exposure of THP-1 cells to LPS. THP-1 cells were incubated with LPS (100 ng/ml) for 0–72 h before
assessing mitochondrial biogenesis and respiration. (A) Mitochondrial mass was assessed by measuring the uptake of NAO using flow cytometry, (positive
control - glucose-free medium supplemented with 5mM galactose) (n = 4). (B) A colorimetric assay was used to assess the activity of the mitochondrial matrix
enzyme citrate synthase (n = 3). (C) mtDNA copy number was determined by measuring MT-ND1 relative to B2M using qPCR (n = 5). (D) The level of TFAM protein
relative to β-actin was determined by Western blot (n = 4). (E) Scatter plot, linear regression and Pearson’s correlation of the relationship between mtDNA copy
number and TFAM protein levels. *p < 0.05, **p < 0.01, ***p < 0.001. (F) Representative images of protein bands for subunits of the five mitochondrial OXPHOS
complexes on PVDF membrane following Western blot and quantification of the subunits of the five mitochondrial OXPHOS complexes relative to β-actin (n = 4).
(G) Representative example of the respiratory profile and (H) oxygen consumption rate for different aspects of mitochondrial respiration following exposure to LPS
(100 ng/ml) for 0–72 h as determined using the Seahorse XF96e extracellular flux analyser (n = 5). (I) A colorimetric assay was used to measure the activity of
OXPHOS complex IV(n = 3). The data are represented as (A) individual values with a line indicating the mean or (B,C,F,H,I) mean ± standard deviation relative to the
mean in the medium control; *p < 0.05, **p < 0.01, ***p < 0.001.
defenses, mitophagy, and mitochondrial biogenesis. In this
model the resultant selective replacement of dysfunctional
mitochondria leads to an increase in overall mitochondrial
efficiency, as evidenced by increased mitochondrial respiration
despite unchanged mitochondrial mass, in association with
the resolution of oxidative stress and the recovery of pro-
inflammatory cytokine release by 72 h.
Mitophagy involves the lysosomal degradation of
mitochondria following encapsulation in an autophagosome
(45). This process is key for the maintenance of quality control
because damaged mitochondria are specifically targeted for
destruction (46). Although data from human studies are
very limited, it appears that mitophagy may be insufficient
during severe sepsis resulting in persistence of dysfunctional
mitochondria that can lead to deficient respiration (47, 48).
Moreover, animal sepsis models suggest that mitophagy is
an important component of the recovery mechanisms, with
inadequate mitochondrial degradation associated with increased
organ damage, persistence of oxidative stress, and exacerbation
of inflammation through increased inflammasome formation
(49–51). In keeping with this, reports in cell culture and murine
models indicate that autophagy and mitophagy are stimulated
following ligand binding to pattern recognition receptors in a
process which is implicated in suppressing pro-inflammatory
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FIGURE 5 | Incubation of monocytes with LPS for 24 h results in reduced ability to release TNFα in response to a second LPS stimulus and increased mtDNA copy
number. Blood monocytes were incubated with LPS (10 ng/ml) before measuring cytokine release and mtDNA copy number. (A) The release of TNFα in response to a
second 4 h exposure to LPS (10 ng/ml) was measured by ELISA (n = 5). (B) mtDNA copy number was determined by measuring MT-ND1 relative to B2M using qPCR
(n = 5). Data are represented as (A) mean ± standard deviation or (B) individual values with a line representing the mean. *p < 0.05 on independent t-test.
cytokine release and oxidative stress through inhibition of the
nucleotide-binding domain, leucine-rich-containing family,
pyrin domain containing-3 (NLRP3) inflammasome (52, 53).
Mitochondrial biogenesis is a dynamic process during which
pre-existing mitochondria grow and divide in response to
physiological conditions or cellular energy requirements (54). It
is controlled by a complex network of hormones and signaling
pathways which regulate the expression of mitochondrial
transcription factors that in turn co-ordinate the expression of
mitochondrial genes in the nuclear and mitochondrial genomes
(55). Mitochondrial biogenesis appears to be an essential
response that is required to compensate for the adverse effects
of inflammation on mitochondrial structure and function (56).
In a wide variety of animal models and a few small observational
human studies there is increasing evidence that expanding the
mitochondrial population promotes the recovery from sepsis
(57–59). The effects of this inflammation-induced mitochondrial
biogenesis may actually extend beyond maintaining homeostasis
and facilitate an increase in overall cellular respiration, as seen in
our model, potentially leading to an increased resistance to the
negative effects of excessive inflammation (36, 60).
Although human data have been lacking, animal models
suggest that there is an integrated up-regulation of mitophagy
and mitochondrial biogenesis following an inflammatory insult
(43). Both processes appear to be directly triggered following
the recognition of inflammatory stimuli; inhibition of Toll-like
receptor-4 (TLR-4, the main pattern recognition receptor for
LPS-induced signaling) after caecal ligation and puncture or
LPS treatment prevents the activation of both mitophagy and
mitochondrial biogenesis (48, 61). Mitochondrial turnover may
be integrated with antioxidant defenses and anti-inflammatory
responses through the activation of redox-sensitive signaling
pathways (62). Murine models suggest that during sepsis the
inducible antioxidant enzyme heme oxygenase-1 stimulates
the expression of nuclear factor (erythroid-derived-2)-like 2
(Nrf2), a transcription factor that binds to anti-oxidant response
elements on gene promoters for transcription factors regulating
mitochondrial biogenesis, mitophagy, and anti-inflammatory
responses (63, 64). Nrf2−/− knockout mice have impaired ability
to upregulate these processes, leading to more severe sepsis
(43, 65). Alternatively, a group of deacetylases termed silent
information regulators (sirtuins), with activity dependent on
the presence of the oxidized form of the respiratory chain
enzyme nicotinamide adenine dinucleotide (NAD+), facilitate
responses to alterations in cellular energy levels and may thus
link metabolism with immunity (66). In the nucleus SIRT1
activates both mitochondrial biogenesis and autophagy, but
is also involved in resolution of inflammation through the
negative regulation of pro-inflammatory pathways (67, 68). In
the mitochondria SIRT3 is essential for effective mitochondrial
biogenesis and can increase OXPHOS activity and activate
antioxidant responses (69). In one study, following exposure to
LPS, the sequential activation of SIRT1 and SIRT3 was found
to integrate the induction of mitochondrial biogenesis with the
down-regulation of pro-inflammatory responses (36). Another
potential link between immunity and mitochondrial homeostasis
is suggested by findings that the intracellular chaperone heat
shock protein-90 (HSP90) is both essential for effective clearance
of defective mitochondria by mitophagy and implicated, through
accumulation at the cell surface, in the suppression of TNFα
production in response to LPS (70, 71).
To our knowledge we have shown for the first time that
mitochondrial biogenesis and mitophagy are important in
the responses of immunologically relevant human cells to
an inflammatory insult, providing important insights into the
compensatory mechanisms that may go wrong during sepsis.
However, it should be noted that this study has some limitations.
Firstly, our model predominantly used THP-1 cells because
human monocytes have considerable inter-individual variability,
a limited life span, a propensity to rapidly differentiate in vitro,
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and are difficult to isolate in large numbers (72, 73). THP-1
cells have similar morphology, surface antigens and secretory
products to blood monocytes and have been used extensively to
study monocyte and macrophage functions (74, 75). However,
they represent a simplified model and have important differences
to humanmonocytes that are particularly relevant when assessing
the response to LPS, including significantly reduced expression
of the LPS receptor CD14 and altered cytokine production (76,
77). In view of this, while we have detected similar effects of
LPS exposure on TNFα release and mtDNA copy number in
monocytes, our results are only suggestive of responses that may
occur in humanmonocytes and an in vivo validation, for example
in a human LPS challenge model, is ultimately required (78).
It should also be noted that, while we have observed
an immune phenotype consistent with endotoxin tolerance,
there are other potential explanations for the decrease in pro-
inflammatory cytokine release following prior exposure to LPS
that have not been fully explored. These include the presence
of LPS-binding protein, a down-regulation in TLR-4 expression
or a failure of internalization of TLR-4-LPS complexes (79,
80). Similarly, although we have found no evidence that LPS
exposure leads to THP-1 cell macrophage-like differentiation,
M2 polarization remains a potential mechanism for the change
in immune phenotype and mitochondrial respiration seen in
this study (81, 82). In addition, endotoxin tolerance is not
an ideal model of sepsis as a single, sterile stimulus does not
mimic the overwhelming, multiple, and persistent inflammatory
triggers seen in sepsis. Rather, by using endotoxin tolerance, we
are likely to mimic the processes occurring when an infection
is successfully cleared instead of a situation in which sepsis
is triggered. Furthermore, the dose of LPS required to induce
endotoxin tolerance in this study (100 ng/ml) is significantly
higher than the concentration of LPS that has been measured in
the serum of patients with septic shock (83). Finally, we have not
elucidated the mechanisms underlying our observations, which
means that causality and the precise relationships between the
changes observed remain to be determined.
In clinical studies and animal models survival and recovery
of cellular functions in sepsis appear to be dependent on
the induction of compensatory responses, including those
aimed at preventing excessive inflammation and those that
maintain mitochondrial homeostasis through the activation of
mitochondrial biogenesis, mitophagy and antioxidant defenses.
Here we show for the first time in human monocyte-like cells
that there is a contemporaneous, co-ordinated upregulation of
mitochondrial biogenesis, mitophagy and antioxidant defenses
during endotoxin tolerance, which results in the resolution of
oxidative stress and increased mitochondrial respiratory activity.
This provides important insights into the relationship between
mitochondria and the innate immune response, as well as the
coordination of compensatory responses that are required to
maintain cell viability and function following an inflammatory
insult. We speculate that these processes may go awry when the
insult leads to sepsis.
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